A new trading day began on Tuesday, with Agenus Inc (NASDAQ: AGEN) stock price down -5.70% from the previous day of trading, before settling in for the closing price of $3.51. AGEN’s price has ranged from $1.38 to $7.34 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 7.90% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 103.54%. With a float of $32.35 million, this company’s outstanding shares have now reached $32.81 million.
In an organization with 316 employees, it is important to assess its efficiency.
Agenus Inc (AGEN) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Agenus Inc is 4.88%, while institutional ownership is 22.94%. The most recent insider transaction that took place on Aug 29 ’25, was worth 12,572,265.
Agenus Inc (AGEN) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -2.04 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 103.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.16% during the next five years compared to 7.90% growth over the previous five years of trading.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
Here are Agenus Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.47. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.13, a number that is poised to hit 0.47 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Let’s dig in a bit further. During the last 5-days, its volume was 0.91 million. That was better than the volume of 0.71 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 36.94%.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 11.63%, which indicates a significant decrease from 25.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was lower than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.04, while its 200-day Moving Average is $4.00. However, in the short run, Agenus Inc’s stock first resistance to watch stands at $3.47. Second resistance stands at $3.63. The third major resistance level sits at $3.73. If the price goes on to break the first support level at $3.20, it is likely to go to the next support level at $3.10. Assuming the price breaks the second support level, the third support level stands at $2.94.
Agenus Inc (NASDAQ: AGEN) Key Stats
With a market capitalization of 112.57 million, the company has a total of 34,008K Shares Outstanding. Currently, annual sales are 103,460 K while annual income is -227,210 K. The company’s previous quarter sales were 30,240 K while its latest quarter income was 63,910 K.
